2001 Nissan Xterra on 2040-cars

Auto blog

Nissan recalling 909k vehicles globally over accelerator issue

Nissan is issuing a massive recall that will see the Japanese automaker repair 908,900 vehicles worldwide, with nearly 100,000 of the affected models in the United States. While an official recall notice from Nissan or the National Highway Traffic Safety Administration is not yet available, Reuters has been able to confirm the recall with Nissan.
Nissan's recall is kind of the opposite of the Toyota unintended acceleration, in that it covers a lack of acceleration. According to the report, a sensor in the gas pedal can develop faults, leading to a sluggish acceleration or an outright stall regardless of how much throttle the driver dials in. The huge recall covers mostly Japanese domestic models like the Serena, X-Trail, Lafesta and Fuga, which make up for 764,800 of the 908,900 faulty vehicles. However, 98,300 Infiniti M sedans are being recalled in the US, although it's unclear at this time which model years and trims are affected. The remaining vehicles are found in Europe and Oceania, according to Nissan spokesman Chris Keefe.
No injuries or accidents have been reported due to the faults. The 90-minute repair will see techs replace the accelerator pedal and tweak the engine control programs. We'll update this story as soon as Nissan or NHTSA makes an official statement.

Infiniti EV coming in 2021

Infiniti announced that it will offer new electrified vehicles starting in 2021. Nissan CEO Hiroto Saikawa said that its luxury brand will build its first all-electric car in 2021, as well as new "e-Power" vehicles – series hybrids with batteries charged by gasoline generators. Nissan has introduced e-Power vehicles in other markets, including the Note e-Power and the Serena e-Power minivan. Now it will extend that technology to Infiniti, providing a similar driving experience to an EV with the convenience of a gas-powered vehicle. Infiniti also said that we can expect "beautiful vehicles" like the Q Inspiration Concept that debuted at the 2018 Detroit Auto Show. Infiniti doesn't plan on producing the Q Inspiration, but it will certainly influence future vehicles in terms of both styling and technology. The Q Inspiration uses variable compression technology, which the company intends to use to improve efficiency and performance of its gasoline-powered cars. Infiniti expects half of its global sales to be electric vehicles by 2025 (it's not clear whether the automaker is lumping series hybrids into the electric vehicle category). And while there's no way that Infiniti will release a production version of its all-electric Prototype 9 EV, seen above, we'll hold onto that dream anyway. Related Video: This content is hosted by a third party. To view it, please update your privacy preferences. Manage Settings.

Nissan had to re-edit this commercial two times to placate Aussie ad watchdog [w/poll]

Nissan recently aired a commercial in Australia for its Pulsar SSS hatchback - think of it as a five-door relative of our Sentra - in which a couple is seen hastily making their way to the hospital ahead of giving birth. But the ad you can watch now isn't the same ad that aired originally - in fact, Nissan had to re-edit the commercial twice before the Australian Advertising Standards Bureau (ASB) would accept it.
According to Go Auto, the original ad received complaints that it depicted unsafe and reckless driving, including speeding, following cars too closely and screeching to a halt upon arriving at the hospital. One of the complaints reportedly read: "The advertisement promotes driving behavior (rapid acceleration/deceleration/changes of direction) that is counter to sound medical advice regarding the carriage of heavily pregnant women in motor vehicles."
In the first edit, Nissan lowered the vehicle's engine noise, removed the woman's speech urging the man to drive faster ("Go, go, go!") and inserted a disclaimer that read "Filmed under controlled conditions," according to Go Auto, but all of that still wasn't enough to appease the ASB.